Clinical Trials Directory

Trials / Completed

CompletedNCT04063579

Cardiac Magnetic Resonance Assessment for Heart Failure With Preserved Ejection Fraction

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
172 (actual)
Sponsor
The University of Hong Kong · Academic / Other
Sex
All
Age
Healthy volunteers
Accepted

Summary

This is a prospective study that aims to define the utility of cardiac magnetic resonance feature tracking (CMR-FT) as a non-invasive quantification tool to assess diastolic functionality in patients with Heart Failure with preserved ejection fraction.

Detailed description

Despite the increasing prevalence and poor prognosis of HFpEF worldwide, it is facing diagnostic challenges due to its non-specific clinical manifestations. Currently, echocardiography serves as the main diagnostic tool, but alternatives are limited to less preferred invasive procedures in most clinical situations. It is therefore proposed to investigate HFpEF using cardiovascular magnetic resonance imaging (CMR), as an alternative non-invasive diagnostic tool which carries lower risk than invasive procedures. The study aims to: (1) access the utility of CMR-FT as a new indicator to diagnose diastolic dysfunction by differentiating HFpEF patients from non-HFpEF patient and normal volunteers. (2) Compare accuracy of CMR-FT to CMR tagging and phase contrast imaging.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTCardiac Magnetic Resonance, Echocardiogram, Blood investigation (NT-proBNP), cardiac catheterizationImaging, blood tests, LV pressure measurement
DIAGNOSTIC_TESTCardiac Magnetic Resonance, Echocardiogram, Blood investigation (NT-proBNP)Imaging and Blood tests

Timeline

Start date
2018-06-01
Primary completion
2021-09-29
Completion
2021-12-31
First posted
2019-08-21
Last updated
2023-05-10

Locations

1 site across 1 country: Hong Kong

Source: ClinicalTrials.gov record NCT04063579. Inclusion in this directory is not an endorsement.